| First Author | Gerdes Gyuricza I | Year | 2020 |
| Journal | Eur J Hum Genet | Volume | 28 |
| Issue | 9 | Pages | 1292-1296 |
| PubMed ID | 32514132 | Mgi Jnum | J:299063 |
| Mgi Id | MGI:6490115 | Doi | 10.1038/s41431-020-0666-0 |
| Citation | Gerdes Gyuricza I, et al. (2020) Is HSPG2 a modifier gene for Marfan syndrome?. Eur J Hum Genet 28(9):1292-1296 |
| abstractText | Marfan syndrome (MFS) is a connective tissue disease caused by variants in the FBN1 gene. Nevertheless, other genes influence the manifestations of the disease, characterized by high clinical variability even within families. We mapped modifier loci for cardiovascular and skeletal manifestations in the mg(loxPneo) mouse model for MFS and the synthenic loci in the human genome. Corroborating our findings, one of those loci was identified also as a modifier locus in MFS patients. Here, we investigate the HSPG2 gene, located in this region, as a candidate modifier gene for MFS. We show a correlation between Fbn1 and Hspg2 expression in spinal column and aorta in non-isogenic mg(loxPneo) mice. Moreover, we show that mice with severe phenotypes present lower expression of Hspg2 than those mildly affected. Thus, we propose that HSPG2 is a strong candidate modifier gene for MFS and its role in modulating disease severity should be investigated in patients. |
